Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Republic of Korea.
Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Republic of Korea; Department of Chemistry, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Cell Signal. 2014 Feb;26(2):398-408. doi: 10.1016/j.cellsig.2013.08.002. Epub 2013 Aug 24.
TMPRSS4 is a novel type II transmembrane serine protease that is highly expressed in pancreatic, thyroid, colon, and other cancer tissues. Previously, we demonstrated that TMPRSS4 mediates tumor cell invasion, migration, and metastasis. However, the mechanisms by which TMPRSS4 contributes to invasion are not fully understood. Here, we demonstrated that TMPRSS4 induced the transcription of the urokinase-type plasminogen activator (uPA) gene through activating the transcription factors Sp1, Sp3, and AP-1 in mainly a JNK-dependent manner and that the induction of uPA was required for TMPRSS4-mediated cancer cell invasion and signaling events. In addition, the uPA receptor was involved in TMPRSS4-induced signaling activation and subsequent uPA expression probably through its association with TMPRSS4 on the cell surface. Immunohistochemical analysis showed that uPA expression was significantly correlated with TMPRSS4 expression in human lung and prostate cancers. These observations suggest that TMPRSS4 is an important regulator of uPA gene expression; the upregulation of uPA by TMPRSS4 contributes to invasion and may represent a novel mechanism for the control of invasion.
TMPRSS4 是一种新型的 II 型跨膜丝氨酸蛋白酶,在胰腺、甲状腺、结肠和其他癌症组织中高度表达。先前,我们证明了 TMPRSS4 介导肿瘤细胞的侵袭、迁移和转移。然而,TMPRSS4 促进侵袭的机制尚未完全阐明。在这里,我们证明 TMPRSS4 通过主要依赖于 JNK 的方式激活转录因子 Sp1、Sp3 和 AP-1 诱导尿激酶型纤溶酶原激活物 (uPA) 基因的转录,并且 uPA 的诱导对于 TMPRSS4 介导的癌细胞侵袭和信号事件是必需的。此外,uPA 受体参与了 TMPRSS4 诱导的信号激活,随后的 uPA 表达可能是通过其与细胞表面上的 TMPRSS4 结合而发生的。免疫组织化学分析显示,uPA 的表达与人肺和前列腺癌中的 TMPRSS4 表达显著相关。这些观察结果表明,TMPRSS4 是 uPA 基因表达的重要调节剂;TMPRSS4 上调 uPA 有助于侵袭,可能代表了侵袭控制的一种新机制。